Author Archives: Thomas E. Love

Landmark study of Under-diagnosis and Under-treatment of Hypertension in U.S. Kids

By | November 22, 2016

Hypertension is already nicknamed “the silent killer”, and for children and adolescents ages 3 -18, it could easily be called the under-diagnosed disease based on the results of a study published today in Pediatrics. The report’s lead author, Dr. David Kaelber, Chief Medical Informatics Officer at MetroHealth and Director of Health Care Informatics at the Center for Health Care Research and Policy explains the results here. Even though children’s blood pressure is routinely checked during office visits, physicians aren’t interpreting the results and following the appropriate guidelines for treatment…

Bolen and colleagues find newer diabetes drugs to be no safer than older drugs

By | November 9, 2016

In an article published on June 7th, 2016 in the Annals of Internal Medicine, Dr. Shari Bolen and colleagues from Johns Hopkins University compare the effectiveness and safety of most diabetes medications alone and in combination with metformin.  They found that metformin, one of the older medications, is still the safest and most effective diabetes medication…

New study finds heart failure readmission associated with poorer long-term outcomes and cost for Medicare patients

By | November 1, 2016

In a study of more than 7500 Medicare beneficiaries hospitalized for heart failure in 1998-2001, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost. Published this month in the American Journal of Medicine. the study, led by researchers at the Veterans Affairs Medical Center of Washington, DC, was co-authored by Dr. Thomas Love, director of Biostatistics and Evaluation for the Center for Health Care Research and Policy…

Study finds no strong link between spironolactone therapy and readmission for heart failure in patients with reduced ejection fraction

By | November 1, 2016

A discharge prescription for spironolactone had no association with 30-day all-cause readmission among older, hospitalized Medicare beneficiaries with heart failure and reduced ejection fraction who were eligible for spironolactone therapy. The study, published this month by the International Journal of Cardiology, was led by researchers at Georgetown University and the VA Medical Center of Washington DC, and co-authored by Dr. Thomas Love, Director of Biostatistics and Evaluation at the Center for Health Care Research and Policy…

David Kaelber named one of Health Data Management’s 30 Leading CMIO Experts in Health Care

By | July 22, 2016

David Kaelber, MD, PhD, FAAP, FACP, Chief Medical Informatics Officer and Vice President of Health Informatics for the MetroHealth System, and Director of Health Care Informatics at the Center for Health Care Research and Policy, was recently recognized as one of 2016’s 30 leading CMIO experts. The list is made up of informatics officers from all over the country who represent leading voices in the CMIO community, and recognizes their current and past influence to mold the field.

Love Named Fellow of the American Statistical Association

By | June 19, 2013

Thomas Love, Director of the Center`s Biostatistics & Evaluation Unit, and Professor of Medicine, Epidemiology & Biostatistics at CWRU has been named a fellow of the American Statistical Association (ASA), the nationÕs preeminent professional statistical society, announced ASA President Marie Davidian. ÒI congratulate Thomas on being honored as a new ASA Fellow,Ó said Davidian. ÒHis Read More

Observational Study Suggests that ARBs may be a better choice than ACE-inhibitors in Certain Elderly Heart Failure Patients

By | October 31, 2011

A team of researchers, including Center faculty member Thomas E. Love, Ph.D., reported important differences in the ways in which various heart failure drugs appear to work, depending on whether the patient has systolic or diastolic heart failure. A Reuters Health report on the study, which suggests that angiotensin receptor blockers (ARBs) may have an Read More

2009 Scholarship in Teaching Award

By | February 16, 2010

Thomas E. Love, Ph. D. was selected for a 2009 Scholarship in Teaching Award by CWRU`s School of Medicine, for his work in developing and leading the instruction of Statistical Thinking for Clinical Research, a semester course for post-doctoral physician-scientists in biostatistics as part of the Clinical Research Scholars Program. Dr. Love was also honored Read More